Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-290-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From September 26th to December 1th, 1994
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Guinea pig maximisation test was available
Test material
- Reference substance name:
- SImilar Substance 01
- IUPAC Name:
- SImilar Substance 01
- Test material form:
- solid: particulate/powder
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: CIBA-GEIGY Limited
- Weight at study initiation: 301-421 g
- Housing: individually in Macrolon cages (type 3) randomly
- Diet (e.g. ad libitum): ad libitum standard guinea pig pellets -NAFAG No. 845, Gossau SG
All batches of the diet are assayed for nutritive ingredients and contamination level by the manufacturer.
- Water (e.g. ad libitum): fresh water
The drinking water quality fulfilled the critical parameters in the specifications of the "Schweizerisches Lebensmittelbuch" (Edition 1972).
- Acclimation period: from 21th of September 1994
- Sensitivity of the strain: checked once or twice a year with a known mild to moderate sensitiser, such as mercaptobsnzothiazole, hexyl cinnamic aldehyde or potassiumdichromate.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3°C
- Humidity (%): 30 to 70%
- Photoperiod (hrs dark / hrs light): 12 hours light cycle day.
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Concentration / amount:
- INTRADERMAL INJECTION: 5 % in physiological saline (w/v).
EPIDERMAL APPLICATION: 30 and 50 % in physiological saline
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- INTRADERMAL INJECTION: 5 % in physiological saline (w/v).
EPIDERMAL APPLICATION: 30 and 50 % in physiological saline
- No. of animals per dose:
- INTRADERMAL APPLICATION
Three pairs of intradermal injections (0.1 ml per injection):
- adjuvant/saline mixture 1:1 (v/v)
- 5 % FAT 21070/B in physiological saline (w/v)
- 5 % FAT 21070/B in the adjuvant/saline mixture (w/v)
EPIDERMAL APPLICATION
The application site of all animals was pretreated with 10 % sodium-laurylsulfate (open application)
- 50 % FAT 21070/B in physiological saline
CHALLENGE
- 30 % FAT 21070/B in physiological saline - Details on study design:
- RANGE FINDING TESTS:
The test started with the minimum number of animals (5 per sex for the test group and 5 of one sex for controls). After the challenge procedure, it was
not possible to conclude if the test substance is a sensitiser or not and therefore testing in additional animals was performed to give a total of 20 test and 10 controlanimals.
MAIN STUDY
A. INDUCTION EXPOSURE: INTRADERMAL INJECTION
- No. of exposures: 3 pairs
- Control group: adjuvant/saline mixture and physiological saline
- Site: left and right side of the shaved neck
- Frequency of applications: three simultaneously
A. INDUCTION EXPOSURE: EPIDERMAL APPLICATION
- No. of exposures: 6 animals
The application site of all animals was pretreated with 10% sodium-laurylsulfate (open application)
- Type of application: on a filterpaper patch patch 2x4 cm; 0,4 g per patch; occluded administration;
- Site: the neck of the animals
- Duration: 48 h
- Control group: a physiological saline only
B. CHALLENGE EXPOSURE
- No. of exposures: 6 animals
- Type of application: flank in physiological saline; 2x2 cm patch; 0.2 g per patch
- Site: the neck of the animals
- Duration: 24 h
- Control group: a physiological saline only
Results and discussion
- Positive control results:
- Number of positive animals per group after occlusive epidermal application : 0 (24 and 48 hours)
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- after occlusive epidermal application
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- after occlusive epidermal application
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: control group- vehicle control
- Dose level:
- epidermal application-removal of dressing
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- DRAIZE score= erythema; edema
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: control group- test article control
- Dose level:
- epidermal application-removal of dressing
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- DRAIZE score= erythema; edema
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: control group-vehicle control
- Dose level:
- epidermal application-removal of dressing
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- DRAIZE score= erythema; edema
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: control group- test article control
- Dose level:
- epidermal application-removal of dressing
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- DRAIZE score= erythema; edema
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: test group-vehicle control
- Dose level:
- epidermal application-removal of dressing
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- DRAIZE score=erythema; edema
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: test group- vehicle control
- Dose level:
- epidermal application-removal of the dressing
- No. with + reactions:
- 4
- Total no. in group:
- 20
- Clinical observations:
- DRAIZE score=erythema; edema
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: test group-vehicle control
- Dose level:
- epidermal application-removal of the dressing
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- DRAIZE score=erythema; edema
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: test group-test article
- Dose level:
- epidermal application-removal of the dressing
- No. with + reactions:
- 4
- Total no. in group:
- 20
- Clinical observations:
- DRAIZE score=erythema; edema
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 30% intradermal injections of an adjuvant/saline mixture 1:1 (v/v; 0.1 ml per injection)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- erithema, edema
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50% intradermal injections of an adjuvant/saline mixture 1:1 (v/v; 0.1 ml per injection)
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- erythema, edema
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 30% intradermal injections of an adjuvant/saline mixture 1:1 (v/v; 0.1 ml per injection)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- erythema;edema
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50% intradermal injections of an adjuvant/saline mixture 1:1 (v/v; 0.1 ml per injection)
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Clinical observations:
- edema
Any other information on results incl. tables
After removal of the dressing on day 10, irritation of the epidermal application site was observed in 10/10 control and in 20/20 test group animals.
Body weights were not affected by treatment.
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified as a skin sensitiser according to the CLP Regulation (EC) No. 1272/2008
- Conclusions:
- Under the experimental conditions employed, 10 % and 15 % of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings, respectively.
- Executive summary:
The determination of the sensitizing potential was determined by a Maximixation test, according to OECD 406 guideline and GLP. The reaction on the test substance was observed in Guinea Pigs for 48 hours. Induction reactions, challenge reactions and changes in body weight were observed. Under the experimental conditions employed, 10 % and 15 % of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings, respectively. The test shows low reactions to the test item, up to 15% of positive reaction. Body weights were not affected by treatment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.